Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Myocardial & Hepatic Shear Wave Velocity Measurements in Patients With Non-Reduced-Ejection Fraction Heart Failure and Control Subjects - US Benchmarking Clinical Study

NCT07215715 is registered in ClinicalTrials.gov with eMyosound SAS as lead sponsor.

NCT NCT07215715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Myocardial & Hepatic Shear Wave Velocity Measurements in Patients With Non-Reduced-Ejection Fraction Heart Failure and Control Subjects - US Benchmarking Clinical Study
Lead sponsor
eMyosound SAS
Phase
Observational
Overall status
Recruiting
Start date
September 16, 2025
Completion date
July 31, 2026
Enrollment
150 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

attr-cm (transthyretin amyloid cardiomyopathy), cardiac amyloidosis, hfmref, hfpef - heart failure with preserved ejection fraction, left ventricular hypertrophy